While VHL, TP53, and RB1 are not common coincident mutations in ccRCC, the investigators speculate that this background mimics the copy number alterations of p53 pathway regulators and cell cycle control enzymes typically found in human ccRCC tumors (27). The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.